SUNMED
55552.130 ↑
2.130 ↑
0.030 (1.4%)| High | 2.130 |
| Low | 2.090 |
| Open | 2.100 |
| Volume | 6,750,800 |
| Volume (B/S) | 6,600 / 396,200 |
| Price Bid/Ask | 2.130 / 2.140 |
| 52w | 1.690 - 2.460 |
| ROE | 8.93 |
| P/E | 82.10 |
| EPS | 2.59 |
| DPS | |
| DY | 0.00% |
| NTA | 0.2900 |
| P/B | 7.34 |
| RPS | 16.29 |
| PSR | 13.07 |
| Market Cap | 24.5B |
| Shares (mil) | 11,505.43 |
| RTopQ |
| CAGR |
3Y
8856%
TTM
6498%
5Y
4740%
TTM
7113%
|
|
| RSI(14) | Neutral 54.9 |
| Stochastic(14) | Neutral 44.4 |
| Stochastic RSI(14) | Oversold 0.0 |
| Average Volume (3M) | 0 |
| Relative Volume | 0.0 |
| Financial Year | Revenue ('000) | Net ('000) | EPS | DP% | Net % | Report |
|---|---|---|---|---|---|---|
| 31 Dec, 2026 | 1,259,944 | 111,487 | 0.9700 | 880.41 | ||
| 31 Dec, 2025 | 614,640 | 112,382 | 0.9800 | 590.82 |
| Announced | Financial Year | Subject | EX Date | Payment Date | Amount | Indicator |
|---|
No dividends
| Announced | EX Date | Subject | Ratio | Offer |
|---|
No records
| Name | Price | Change | Volume | Gearing | Premium | Premium % | Maturity | |
|---|---|---|---|---|---|---|---|---|
| SUNMED-CE | 0.270 | 0 | 0 | 3.94 | -0.04 | -1.88 | 2026-10-19 | View |
| SUNMED-CF | 0.200 | 0 | 0 | 5.33 | 0.15 | 7.04 | 2026-10-19 | View |
| SUNMED-CC | 0.170 | 0.005 | 950 | 3.13 | -0 | -0 | 2026-10-29 | View |
| SUNMED-CD | 0.140 | 0 | 1,920 | 7.61 | -0 | -0 | 2026-10-29 | View |
| SUNMED-CH | 0.080 | 0 | 20,000 | 8.88 | 0.11 | 5.16 | 2026-12-11 | View |
| SUNMED-CG | 0.110 | 0 | 0 | 4.84 | 0.01 | 0.47 | 2026-12-11 | View |
| SUNMED-CJ | 0.070 | 0 | 0 | 6.76 | 0.065 | 3.05 | 2026-10-30 | View |
| SUNMED-CI | 0.005 | 0 | 550 | 94.67 | 0.272 | 12.77 | 2026-10-30 | View |
| SUNMED-CK | 0.025 | 0 | 0 | 17.04 | 0.575 | 27 | 2026-11-26 | View |
| SUNMED-CL | 0.080 | 0 | 0 | 6.66 | 0.07 | 3.29 | 2026-10-27 | View |
| SUNMED-CM | 0.035 | 0 | 0 | 30.43 | 0.19 | 8.92 | 2026-10-30 | View |
| SUNMED-CN | 0.015 | 0 | 0 | 50.71 | 0.592 | 27.79 | 2026-12-18 | View |
| SUNMED-CO | 0.035 | 0 | 0 | 24.34 | 0.157 | 7.37 | 2026-11-26 | View |
| SUNMED-CP | 0.025 | 0.005 | 34,744 | 42.6 | 0.2 | 9.39 | 2026-11-30 | View |
| SUNMED-CR | 0.055 | 0 | 6,464 | 19.36 | 0.66 | 30.99 | 2027-03-15 | View |
| SUNMED-CQ | 0.150 | 0 | 2,150 | 7.1 | 0.25 | 11.74 | 2027-03-15 | View |
| SUNMED-CS | 0.085 | 0 | 14,994 | 8.35 | 0.125 | 5.87 | 2027-03-31 | View |
| SUNMED-CT | 0.175 | 0 | 333 | 6.09 | 0.02 | 0.94 | 2027-01-29 | View |
| SUNMED-CU | 0.095 | 0 | 28,100 | 8.01 | 0.116 | 5.45 | 2027-03-25 | View |
| SUNMED-CV | 0.065 | 0 | 0 | 13.11 | 0.282 | 13.24 | 2027-02-26 | View |
| SUNMED-CW | 0.060 | 0 | 31,000 | 11.83 | 0.35 | 16.43 | 2027-05-27 | View |
| SUNMED-CX | 0.065 | 0 | 0 | 8.19 | 0.51 | 23.94 | 2027-08-09 | View |
| SUNMED-CY | 0.065 | 0 | 0 | 13.11 | 0.232 | 10.89 | 2027-04-29 | View |
Recent News
-
选股兼顾保本与增长 末季宜采杠铃策略
(吉隆坡8日讯)美国甚至大马的利率路径看涨,加上高油价推升各项成本,周期股的好日子可能到头,分析员将综指今年杪目标从1775点下调至1700点,预测综指股盈利在2026年增长12.2%,在明年将大幅减速至3.5%,建议采取“杠铃策略”(barbell strategy),即一头押银行和医疗保健守住安全边际,另一头押科技、电力等结构性主题博取增长。肯纳格研究在最新发布的《2026年第四季展望》研究报告中说,目前应该把周期股排除在杠铃的两端之外。报告指出,近期市场的路径不明朗,但大马的结构性增长...Sinchew -
私人医院加床也加专科服务 3大集团扩充迎接求医需求
私人医院加床,也加强专科治疗!大马每1000人仅有2张医院病床,低于发达市场的4.6张,三大医疗集团计划增加43%至逾70%的病床,并发展专科中心,承接更复杂的手术与治疗。...Nanyang -
人口老龄化慢性病患增 私立医疗市场2年增11.4%
在全球人口老龄化、非传染性慢性疾病罹患率持续增长以及私立医疗服务需求等多重因素推动下,大马私立医疗保健市场增长强劲,预计未来两年增长率将达到11.4%。...Nanyang -
GIC出清双威医疗股权 谢富年:这是好事
(吉隆坡1日讯)新加坡主权财富基金GIC出清双威医疗(SUNMED,5555,主要板医疗保健)股权,双威医疗执行主席丹斯里谢富年反称是好事,并认为此举有助股价稳定,且对公司持续获得投资者支持充满信心。谢富年指出,GIC旗下投资工具Greenwood Capital Pte Ltd此次出售约5亿7500万股,是该基金持有双威医疗股权的最后一批股份。他说,这批股份有相当大部分获本地机构承接,包括国民投资机构(PNB)及雇员公积金局(EPF),反映机构投资者对双威医疗的持续兴趣。...Chinapress -
谢富年: 新加坡基金清完5%股权 双威医疗料续获支持
(八打灵再也1日讯)纵使新加坡主权财富基金已出清余下的5%股权,但双威医疗(SUNMED,5555,主板医疗保健组)有信心,可持续获得投资者支持。该公司执行主席丹斯里谢富年今日为旗下白沙罗双威医疗中心主持开幕仪式后指出,新加坡政府投资公司(GIC)透过子公司Greenwood资本私人有限公司卖出的5亿7500万股,是他们在公司持有的最后一批股票。他续指,公司大部分的股票获本地机构投资者,包括国民投资公司(PNB)、雇员公积金局等吸纳,说明机构投资者对双威医疗持续感兴趣。“他们是基金,而基金...Sinchew
Recent Announcements
-
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
-
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
-
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
-
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
-
DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period